206 related articles for article (PubMed ID: 27832663)
61. MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1.
Liu X; Zhou Y; Ning YE; Gu H; Tong Y; Wang N
Onco Targets Ther; 2020; 13():931-944. PubMed ID: 32099397
[TBL] [Abstract][Full Text] [Related]
62. miR-574-5p mediates epithelial-mesenchymal transition in small cell lung cancer by targeting vimentin via a competitive endogenous RNA network.
Sun Y; Yi Y; Gan S; Ye R; Huang C; Li M; Huang J; Guo Y
Oncol Lett; 2021 Jun; 21(6):459. PubMed ID: 33907569
[TBL] [Abstract][Full Text] [Related]
63. Extracellular Vesicle-Derived miR-105-5p Promotes Malignant Phenotypes of Esophageal Squamous Cell Carcinoma by Targeting SPARCL1
He B; Zhang K; Han X; Su C; Zhao J; Wang G; Wang G; Zhang L; Hu W
Front Genet; 2022; 13():819699. PubMed ID: 35309127
[No Abstract] [Full Text] [Related]
64. miR-488-5p promotes esophageal squamous cell carcinoma progression by suppressing the P53 pathway.
Su C; Liu W; Jiang T; Liu J
J Thorac Dis; 2021 Sep; 13(9):5534-5545. PubMed ID: 34659819
[TBL] [Abstract][Full Text] [Related]
65. MicroRNA-146a-5p Mediates High Glucose-Induced Endothelial Inflammation via Targeting Interleukin-1 Receptor-Associated Kinase 1 Expression.
Lo WY; Peng CT; Wang HJ
Front Physiol; 2017; 8():551. PubMed ID: 28824448
[No Abstract] [Full Text] [Related]
66. Esophageal Cancer-Derived Extracellular Vesicle miR-21-5p Contributes to EMT of ESCC Cells by Disorganizing Macrophage Polarization.
Song J; Yang P; Li X; Zhu X; Liu M; Duan X; Liu R
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439276
[TBL] [Abstract][Full Text] [Related]
67. miR-100-5p Inhibits Malignant Behavior of Chordoma Cells by Targeting IGF1R.
Zhang H; Yang K; Ren T; Huang Y; Liang X; Yu Y; Wang W; Niu J; Lou J; Tang X; Guo W
Cancer Manag Res; 2020; 12():4129-4137. PubMed ID: 32606920
[TBL] [Abstract][Full Text] [Related]
68. CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma.
Xu S; Li X; Li L; Wang Y; Geng C; Guo F; Zhang T; Du A; Lu Z; Hui H; Wang Q
Cancer Cell Int; 2021 Mar; 21(1):155. PubMed ID: 33685449
[TBL] [Abstract][Full Text] [Related]
69. Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.
Yi Y; Lu X; Chen J; Jiao C; Zhong J; Song Z; Yu X; Lin B
Exp Ther Med; 2016 Nov; 12(5):3411-3416. PubMed ID: 27882172
[TBL] [Abstract][Full Text] [Related]
70. Cervical Cancer Cells-Derived Extracellular Vesicles Containing microRNA-146a-5p Affect Actin Dynamics to Promote Cervical Cancer Metastasis by Activating the Hippo-YAP Signaling Pathway
Wang W; Wu L; Tian J; Yan W; Qi C; Liu W; Xuan S; Shang A
J Oncol; 2022; 2022():4499876. PubMed ID: 35799607
[TBL] [Abstract][Full Text] [Related]
71. miR-98-5p Alleviated Epithelial-to-Mesenchymal Transition and Renal Fibrosis via Targeting Hmga2 in Diabetic Nephropathy.
Zhu Y; Xu J; Liang W; Li J; Feng L; Zheng P; Ji T; Bai S
Int J Endocrinol; 2019; 2019():4946181. PubMed ID: 31885559
[TBL] [Abstract][Full Text] [Related]
72. Mir-483-5p promotes the malignant transformation of immortalized human esophageal epithelial cells by targeting HNF4A.
Sun J; Li X; Wang W; Li W; Gao S; Yan J
Int J Clin Exp Pathol; 2017; 10(9):9391-9399. PubMed ID: 31966811
[TBL] [Abstract][Full Text] [Related]
73. Expression of miR-146a-5p in breast cancer and its role in proliferation of breast cancer cells.
Gao W; Hua J; Jia Z; Ding J; Han Z; Dong Y; Lin Q; Yao Y
Oncol Lett; 2018 Jun; 15(6):9884-9888. PubMed ID: 29928360
[TBL] [Abstract][Full Text] [Related]
74. Dysregulated Expression of miR-146a and Its Associated Immune Effectors in Peripheral Blood Mononuclear Cells of Esophageal Carcinoma Patients.
Nariman-Saleh-Fam Z; Mansoori Y; Saadatian Z; Tavakkoly-Bazzaz J; Daraei A; Zununi Vahed S; Mahmoodzadeh H; Bastami M
Immunol Invest; 2022 Feb; 51(2):290-300. PubMed ID: 33003976
[TBL] [Abstract][Full Text] [Related]
75. The Oncogenic Activity of
Kurihara-Shimomura M; Sasahira T; Shimomura H; Nakashima C; Kirita T
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30813466
[TBL] [Abstract][Full Text] [Related]
76. MiR-146a-5p targeting SMAD4 and TRAF6 inhibits adipogenensis through TGF-β and AKT/mTORC1 signal pathways in porcine intramuscular preadipocytes.
Zhang Q; Cai R; Tang G; Zhang W; Pang W
J Anim Sci Biotechnol; 2021 Feb; 12(1):12. PubMed ID: 33531066
[TBL] [Abstract][Full Text] [Related]
77. MicroRNA-146a promotes proliferation, migration, and invasion of HepG2 via regulating FLAP.
Wang H; Zhang S; Li T; Wang L; Lv W; Wang S; Ma D; Zang Y; Zhu X; Xu Y; Zheng L; Shen J; Wei W
Cancer Cell Int; 2022 Apr; 22(1):149. PubMed ID: 35410355
[TBL] [Abstract][Full Text] [Related]
78. miR-17-5p and miR-4443 Promote Esophageal Squamous Cell Carcinoma Development by Targeting TIMP2.
Wang X; Han J; Liu Y; Hu J; Li M; Chen X; Xu L
Front Oncol; 2021; 11():605894. PubMed ID: 34778021
[TBL] [Abstract][Full Text] [Related]
79. miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition.
Zhang X; Zhang T; Yang K; Zhang M; Wang K
Onco Targets Ther; 2016; 9():6909-6914. PubMed ID: 27877055
[TBL] [Abstract][Full Text] [Related]
80. Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis.
Luo Q; Feng Y; Xie Y; Shao Y; Wu M; Deng X; Yuan WE; Chen Y; Shi X
Nanomedicine; 2019 Apr; 17():188-197. PubMed ID: 30721753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]